C29H52O
Neat
416.74
Stigmastan-3beta-ol; 19466-47-8; Stigmastan-3.beta.-ol; (3S, 8R, 9S, 10S, 13R, 14S, 17R)-17-[(2R, 5R)-5-ethyl-6-methylheptan-2-yl]-10, 13-dimethyl-2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15, 16, 17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; DTXSID8051835; (3S, 8R, 9S, 10S, 13R, 14S, 17R)-17-((2R, 5R)-5-ethyl-6-methylheptan-2-yl)-10, 13-dimethyl-2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15, 16, 17-tetradecahydro-1H-cyclopenta(a)phenanthren-3-ol; RefChem:185759; DTXCID3030391; Stigmastan-3|A-ol; Stigmastan-3-ol and (3beta)-; (3beta)-Stigmastan-3-ol; beta-Sitostanol; Stigmastane-3-beta-ol; Fucostanol; C29H52O; b-Sitostanol; MFCD11109453; stigmastan-3b-ol; 4a-Methylcampestanol; Dihydro-b-sitosterol
(3S, 8R, 9S, 10S, 13R, 14S, 17R)-17-[(2R, 5R)-5-ethyl-6-methylheptan-2-yl]-10, 13-dimethyl-2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15, 16 and 17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChI=1S/C29H52O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h19-27,30H,7-18H2,1-6H3/t20-,21-,22?,23+,24+,25-,26+,27+,28+,29-/m1/s1